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Background. Experimental models using DNA vaccine has shown that this vaccine is efficient in generating humoral and
cellular immune responses to a wide variety of DNA-derived antigens. Despite the progress in DNA vaccine development, the
intracellular transport and fate of naked plasmid DNA in eukaryotic cells is poorly understood, and need to be clarified in order
to facilitate the development of novel vectors and vaccine strategies. Methodology and Principal Findings. Using confocal
microscopy, we have demonstrated for the first time that after plasmid DNA uptake an inhibition of the acidification of the
lysosomal compartment occurs. This lack of acidification impaired antigen presentation to CD4 T cells, but did not alter the
recruitment of MyD88. The recruitment of Rab 5 and Lamp I were also altered since we were not able to co-localize plasmid
DNA with Rab 5 and Lamp I in early endosomes and late endosomes/lysosomes, respectively. Furthermore, we observed that
the DNA capture process in macrophages was by clathrin-mediated endocytosis. In addition, we observed that plasmid DNA
remains in vesicles until it is in a juxtanuclear location, suggesting that the plasmid does not escape into the cytoplasmic
compartment. Conclusions and Significance. Taken together our data suggests a novel mechanism involved in the
intracellular trafficking of plasmid DNA, and opens new possibilities for the use of lower doses of plasmid DNA to regulate the
immune response.
Citation: Trombone APF, Silva CL, Lima KM, Oliver C, Jamur MC, et al (2007) Endocytosis of DNA-Hsp65 Alters the pH of the Late Endosome/Lysosome
and Interferes with Antigen Presentation. PLoS ONE 2(9): e923. doi:10.1371/journal.pone.0000923
INTRODUCTION
The use of plasmid DNA in vaccinology and gene therapy has
shown that plasmid DNA is efficient in generating humoral and
cell-mediated immune responses to a wide variety of DNA-derived
antigens in various animal models [1]. In the late 1980s, several
groups demonstrated that intramuscular injection of naked DNA
led to its transcription in myocytes resulting in the secretion of the
encoded protein [2,3]. Later studies found foreign gene expression
after direct injection into other tissues such as heart, thyroid, skin
and liver [4–7]. Despite the progress in DNA vaccine de-
velopment, the intracellular transport and fate of naked plasmid
DNA in eukaryotic cells is poorly understood. These details need
to be clarified in order to facilitate the development of novel
vectors and vaccine strategies.
Investigations of the intracellular route of plasmid DNA
adsorbed on cationic polymer, cationic lipid or encapsulated in
polymers have however been widely explored [8–10]. These
studies suggested that formulation with positive charge such as
lipoplex and polyplex were internalized by clathrin-dependent
endocytosis [11]. However, the size, as well as the composition of
the complex can influence the route of internalization. Large
lipoplex (up to 500 nm) complexes preferentially enter the cell by
receptor- and clathrin-independent endocytosis while the smaller
complexes (,200 nm) could be internalized via coated pits
through a non-specific, clathrin-dependent process [12]. The
internalization of DNA entrapped in PLGA polymer occurs by
phagocytosis (for microparticles, 1–10 mm) or through fluid phase
pinocytosis and clathrin-coated pits (for nanoparticles, 70 nm)
[13–15]. In these models, after its uptake, it is thought that plasmid
DNA escapes to the cytoplasm, and that this process occurs
through the disruption of the endo-lysosomal membrane. It is
generally accepted that DNA/lipid cationic complexes fuse with
the endosomal membrane allowing the escape of DNA into the
cytosol [16–18]. The mechanism suggested for cationic polymers is
a ‘‘proton sponge-mediated escape’’ [19,20] by which the free
plasmid DNA which enters the cytoplasm is transported to the
nucleus, where it can then be transcribed.
However, in contrast to complexed plasmid DNA, the in-
tracellular route of naked plasmid DNA, is poorly analyzed and
restricted to the uptake process of the linear molecule or analysis of
the localization of DNA in permeabilized cells [21–23]. Some
experiments have demonstrated that the uptake of naked DNA by
muscle cells occurs through caveolae, [24,25] while in keratino-
cytes, the uptake of naked DNA occurs by macropinocytosis [26].
After the uptake, there is a generalized concept that DNA is
localized in endosomes from which it can escape to the cytoplasm
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degradation. Another possibility is that the DNA could escape to
the cytoplasm even from lysosomes, and once in the cytosol, naked
DNA could reach the nucleus to be transcribed [10,27,28]. In
addition, the trafficking and cell activation by CpG motifs via
TLR is well known, and for TLR9 MyD88 molecules has been
shown to play an essential role in cell activation [29–31].
Our studies have focused on intramuscular delivery of naked
plasmid DNA encoding M. leprae 65-kD heat shock protein as
a vaccine against tuberculosis. We observed that this form of
administration results in good immune induction, as well as
protection against virulent M. tuberculosis challenge [32,33]. In
addition, in heavily infected mice, vaccination with Hsp65-
encoding DNA can switch a relatively inefficient immune response
that produces only bacterial stasis to an efficient response that kills
bacteria [34,35]. However, one of the principal problems in DNA
vaccine strategy is the high amount of DNA needed to induce an
efficient immune response due to the adverse environment for
plasmid DNA in eukaryotic cells. Therefore, an understanding of
intracellular plasmid DNA trafficking could help in reducing the
DNA dose. In this study we analyzed the fate of naked DNA-
Hsp65 in macrophages and dendritic cells, in order to address the
mechanisms involved in intracellular DNA trafficking. We
demonstrate unexpected results concerning plasmid-lysosome
interactions and present original data that opens a novel way to
use plasmid DNA to manipulate the immune response.
RESULTS
The intracellular compartmentalization of plasmid
DNA by J774 macrophage
In order to determine the mechanism involved in plasmid DNA
compartmentalization by eukaryotic cells we used J774 macro-
phages as a model. Transferrin, a marker of early endosomes, was
used to investigate the presence of plasmid DNA in early
endosomes (Figure 1). The results showed that in J774 cells, after
15 minutes, the plasmid DNA and the transferrin were colocalized
in early endosomes in peripheral cytoplasmic compartments
(Figure 1C). However, after 30 minutes, plasmid DNA no longer
colocalized with early endosomes (Figure 1F). Even though the
DNA was present in vesicles labeled with transferrin, suggesting
that the uptake was receptor mediated in J774 cells, we did not
observe co-localization with the early endosome marker Rab 5
after 5 or 15 minutes (Figures 1G and 1H).
Plasmid DNA inhibits acidification of lysosomes
Since plasmid DNA was no longer localized in early endosomes
after 30 minutes, we investigated if the DNA was now present in
late endosomes/lysosomes. To determine whether the plasmid was
localized in these compartments, J774 cells were incubated with
pcDNA3-Hsp65–Alexa 488 in the presence of LysoTracker Red,
a marker for late endosomes and lysosomes. As shown in Figure 2
and Figure 3, fluorescent DNA was not co-localized with
LysoTracker Red in the endo-lysosomal compartment at any of
the times points analyzed (24 h–120 h). Similar results were
observed in peritoneal macrophages, as showed in Figure 2 and
Figure 3 (only 24 h and 72 h time points are shown). To confirm
these results, pcDNA3-Hsp65-Alexa 488 was incubated with Texas
Red dextran, a commonly used marker for lysosomes or endosomes
depending on loading and chase times. Significant co-localization
was detected after 24 h (Figure 4C), suggesting that the plasmid
DNA was in lysosomes. The fact that plasmid DNA was not co-
localizedwithLysoTrackerRed,butwascolocalizedwithTexasRed
dextran, implies that when DNA is present in lysosomes it can
interfere with the acidification of secondary endosomes/lysosomes
(necessary for LysoTracker red accumulation). To eliminate the
possibility that the observed inhibition of acidification was not the
result of fluorocrome interference, we used unlabeled plasmid DNA
and the results did not change (Figure 2J).
In the experiments using spleen-derived dendritic cells (SDCs),
some colocalization of the DNA-Alexa 488 and LysoTracker Red
was detected after 1 hour. However, only a few vesicles containing
DNA were labeled with LysoTracker (Figures 5A and 5B). These
Figure 1. Visualization of plasmid DNA compartamentalization: the
plasmid DNA co-localizes with transferrin in J774 cells. J774 cells were
incubated with DNA-Alexa 488 (green) for 15 minutes (A and C) and
30 minutes (D and F). Transferrin conjugated to Alexa 594 (red) was
used as marker of the early endosomes (B and E). While the plasmid
DNA is colocalized with transferrin within 15 minutes (C, yellow,
arrows), after 30 minutes, the plasmid DNA not was colocalized with
these vesicles (F, arrow). (G–H): J774 cells were incubated with
fluorescent DNA for 5 minutes (G) and 15 minutes (H); and cells
immunostained for Rab5 (red), another marker of early endosomes.
Plasmid DNA not was colocalized with Rab 5. Confocal images.
doi:10.1371/journal.pone.0000923.g001
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inhibit lysosomal acidification in SDCs. To confirm these results,
pcDNA3-Hsp65-Alexa 594 was incubated with DQ Ovalbumin,
a self-quenched conjugate of ovalbumin that exhibits bright green
fluorescence upon proteolytic degradation. As shown in Figure 5C,
after 1 minute DQ Ovalbumin was degraded (green color) as the
plasmid was not captured to any extent (not red color). After 24 h
several colocalization points were observed (Figure 5D-arrow 1)
and after 72 h less colocalization was detected (Figure 5E-arrow 1),
suggesting that DNA uptake (Figure 5E-arrow 2) inhibited the
acidification of the vesicles, preventing the OVA proteolytic
degradation.
At all time points (1 h–120 h) DNA was localized in vesicles and
after 96 h the vesicles containing plasmid DNA were localized
around nuclei (Figure 3F and 3I). These results demonstrate that
after endocytosis plasmid DNA remained in the vesicles until it
Figure 2. Intracellular trafficking of plasmid DNA. Confocal images of J774 cells (A–F) and peritoneal macrophages (G–I) incubated with DNA-Alexa
488 (green-A, D and G) for 24 hours (A–C; G–I) and 48 hours (D–F). LysoTracker Red was used as a marker for late endosomes and lysosomes (B, E and
H). Plasmid DNA was not colocalized with LysoTracker Red which had a very weak signal (C, F and I). DAPI (Molecular Probes) was used to visualize
nuclei (I and J). Note that the inhibition of acidification observed was not the result of fluorocrome interference, since we use plasmid DNA without
labeling and there was no labeling with LysoTracker Red (J). (J): Unlabeled plasmid DNA plus LysoTracker Green. (K): Lysotracker Red without DNA.
doi:10.1371/journal.pone.0000923.g002
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does not escape from the endo-lysososomes to the cytoplasm
(Figures 3 and 4).
In spite of the fact that DNA was present in lysosomes we did
not observe any colocalization, after 24 hours (Figures 4D and 4F),
with Lamp I (lysosome associated membrane protein), a protein
mainly localized in the limiting membranes of lysosomes and late
endosomes.
DNA treatment impairs KLH antigen presentation
To investigate the importance of the inhibition of the acidification
of late endosomes/lysosomes by the plasmid DNA, the process of
antigen presentation was analyzed. KLH antigen presentation was
used as a model. The results showed that plasmid DNA completely
inhibited the KLH antigen presentation when the DNA (20 mg)
was added to the culture simultaneously with KLH, and antigen
presentation was impaired when DNA was added at 24 h, 48 h or
72 h before exposure to KLH. The cells without plasmid DNA
treatment showed antigen specific proliferation as a result of
antigen presentation, while treatment with Con A (40 mg/ml), as
a positive control, also resulted in proliferation (Figure 6).
Plasmid DNA was internalized by TLR9 KO cells and
Myd88 recruitment was not affected by pH of
endososomes
As antigen presentation was altered in the presence of lower doses
(20 mg) of plasmid DNA treatment (since in vaccination with DNA
we used 300 mg of the plasmid DNA), we also investigated the
Figure 3. Intracellular trafficking of plasmid DNA. Confocal images of J774 cells (A–I) and peritoneal macrophages (J–L) incubated with DNA-Alexa
488 (green, A, D, G and J) for 72 h (A–C; J–L), 96 h (D–F) and 120 h (G–I). The LysoTracker Red was used as a marker of late endosomes and lysosomes
(B, E, H and K). Plasmid DNA did not colocalize with LysoTracker Red’s weak signal (C, F, I and L), and after 96 h and 120 h, fluorescent DNA was
concentrated around the nuclei (F and I). DAPI (Molecular Probes) was used to visualize nuclei (C, F, I and L). In I cells are also seen in the Z axis.
doi:10.1371/journal.pone.0000923.g003
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cruitment, classically triggered by CpG motifs present in plasmid
DNA. The results demonstrated that DNA could be internalized
by TLR9 KO cells and the recruitment of Myd88 to vesicles was
not modified in Raw-Myd88GFP cells (Figure 7). These results
suggest that the uptake of the plasmid DNA may be independent
of TLR9 and alcalinization of endocytic vesicles does not interfere
with MyD88 recruitment to the lysosomal membrane.
DISCUSSION
This work reports the basic mechanisms of intracellular DNA
plasmid trafficking and opens new perspectives for the use of
plasmid DNA in immune response control and vaccinology since it
can modify the endosome/lysosome pH and interfere with antigen
presentation. The normal endocytic processing of macromolecules
in antigen presenting cells results in the internalization of
specialized regions of the plasma membrane as well as small
volumes of extracellular fluid. This process occurs by multiple
mechanisms such as clathrin-mediated endocytosis, caveolae-
mediated endocytosis, clathrin- and caveolae- independent
endocytosis and macropinocytosis [36]. After internalization,
macromolecules can traffic through the cell in endosome/
lysosome compartments that can be identified by labeling of their
intrinsic protein markers. For example, early endosomes can be
identified by the presence of Rab5, and late endossome/lysosome
by Lamp I [37,38]. Plasmid DNA, in order to be transcribed and
then activate the immune response, must surmount various
cellular barriers such as the plasma membrane, endo-lysosomal
compartments, transport through the cytoplasm and finally, the
nuclear envelope. First, the naked DNA needs to be captured by
an antigen presenting cell and internalized. This process, like
others involved in the plasmid trafficking, is poorly understood.
Wolff et al. [24] were the first to demonstrate that naked DNA is
taken up by skeletal muscle via caveolae. Alternatively, macro-
pinocytosis of naked DNA was showed in keratinocytes [26]. Our
results suggest that in J774 cells the plasmid DNA appears to
follow the same initial endocytic pathway as transferrin since the
DNA was colocalized with transferrin. These results suggest that
the endocytosis occurs via clathrin-coated pits [36], but that Rab 5
does not seem to be involved in the fusion and motility of the early
endosomes containing plasmid DNA.
In addition, experiments with DNA and caveolin-coated pit
markers showed no co-localization (data not shown). Clathrin
mediated endocytosis was also recently described for uptake of
CpG DNA by dendritic cells [39]. However, Ahmad-Nejad et al.
[40] showed that endocytosis of CpG motifs was dependent on
Rab5 for endosomal transport. Normally, Rab5 is required for
homotypic fusion of early endosomes as well as endosomal
vesicular trafficking [41–43]. The alteration in vesicle pH seen in
the present experiments may explain the lack of involvement of
Rab 5 seen with the plasmid DNA.
Our data demonstrated that after uptake of plasmid DNA, it
moves out of early endosomes, but remains in vesicles until it
arrives close to the nucleus, suggesting that the bulk of the
plasmids do not escape into the cytoplasm.
This is the first time that this intracellular pathway has been
reported for naked plasmid DNA. In delivery systems involving
DNA complexed to synthetic carrier molecules, such as cationic
lipids or polymers escape to the cytoplasm has been demonstrated.
With cationic lipids as the carrier, the disruption of the endo-
lysosomal membrane occurs through the interaction of positively
charged cationic lipids with the negatively charged endosome/
lysosome membrane, leading to membrane destabilization and
Figure 4. Intracellular trafficking of plasmid DNA. Confocal images of peritoneal macrophages incubated with DNA-Alexa 488 (green, A) for
24 hours. Texas Red dextran was used as lysosomal marker (B). Plasmid DNA was incubated with dextran and significant colocalization was observed
(C, arrow 1). (D–F): J774 cells were incubated with DNA-Alexa 488 for 24 hours and the cells immunostained for LAMP I (red, lysosomal marker-E).
Plasmid DNA did not colocalize with LAMP I (F, arrow 2).
doi:10.1371/journal.pone.0000923.g004
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cationic polymers, the suggested mechanism is a ‘‘proton sponge-
mediated escape’’. This theory proposes that cationic polymers
have the ability to buffer endosomal pH thus causing an osmotic
swelling of the endosomes, due to an increased influx of protons
resulting in an influx of chloride ions and water [19,20].
Unlike the cationic carriers, naked plasmid DNA has a negative
charge similar to the endo-lysosomal membrane. The charge
similarity would result in a lower association between the plasmid
DNA and endo-lysosomal membrane, which then impedes the
escape of the plasmid into the cytoplasm. Considering that
cytoplasm is composed of a meshworks of cytoskeletal filaments,
a variety of organelles and has a high protein concentration, the
diffusion of large macromolecules such as DNA may be limited
[44]. If the plasmid DNA stays in vesicles it may be able to move
through the cytoplasm more easily. However, we have not yet
elucidated the exact mechanism by which the plasmid DNA
remains in the vesicles or the biological relevance of this.
Importantly, we observed that the plasmid seems to inhibit the
acidification of the late endosomes/lysosomes. The exact mech-
anism by which plasmid DNA influences the pH of the lysosome
remains unknown, but this strategy presumably allows the plasmid
DNA to avoid degradation by lysosomal enzymes including
DNases [45,46] and prevents a change in the plasmid conforma-
tion thereby reducing the efficiency of transcription. Moreover, the
increase in lysosomal pH did not alter the uptake of DNA, since
treatment with chloroquine also did not interfere with this process
(Figure S1).
Using immature SDCs, we observed that the majority of the
vesicles with plasmid DNA did not colocalize with LysoTracker,
showing that, as previously described for macrophages, the
alteration of pH occurs in various APC types. Moreover, the
alteration of pH was also demonstrated when the incubation with
DNA prevented the OVA proteolytic degradation (Figure 5). Also
the vesicles containing plasmid DNA did not immunolable with
the Lamp I (Figure 4), suggesting that the endosomal pH
modification could interfere with the recruitment of this molecules
to vesicles. Another possibility is that DNA could bind to Lamp I
and interfere with its detection.
Furthermore, the lack of Rab5 and Lamp1 appears not to
interfere with the migration of these vesicles to the peri-nuclear
region. We also analyzed if the plasmid uptake was dependent on
TLR9. Our results showed that the plasmid uptake was
independent of the presence of TLR9 receptor. These results
were expected, since studies showed that TLR9 is localized in the
endoplasmatic reticulum of the dendritic cells and macrophages
[39] and not localized in the plasma membrane. Since the cellular
activation after CpG stimulation occurs via MyD88 recruitment,
Figure 5. Visualization of the intracellular trafficking of plasmid DNA.
Confocal images of spleen-derived dendritic cells (SDCs) incubated with
DNA-Alexa 488 (green) for 1 hour (A–B). LysoTracker Red was used as
marker for late endosomes and lysosomes. After the uptake the
majority of the vesicles with plasmideal DNA were not colocalized with
LysoTracker Red (A and B, -red, arrows 1). However, some colocalization
was detected (B, yellow, arrows 2). (C–E): Visualization of the inhibition
of the acidification of late endosomes/lysosomes by the plasmid DNA.
Confocal images of spleen-derived dendritic cells (SDCs) incubated with
DNA-Alexa 594 (red) and DQ Ovalbumin simultaneously (C: 1 min; D:
24 h and E: 72 h). DQ Ovalbumin is a self-quenched conjugate of
ovalbumin that exhibits bright green fluorescence upon proteolytic
degradation. It’s was used as tool to determined inhibition of the
acidification of late endosomes/lysosomes by the plasmid DNA. At
1 minute DQ Ovalbumin was degraded (green color) and the plasmid
not was captured yet (not red color). After 24 h several colocalization
points was observed (D-arrow 1) and after 72 h only some colocaliza-
tion was detected (E-arrow 1), suggesting that DNA (red color, E-arrow
2) inhibited the acidification of the vesicles, prejudicing the OVA
proteolytic degradation.
doi:10.1371/journal.pone.0000923.g005
Figure 6. DNA treatment impairs KLH antigen presentation.
Peritoneal macrophages were incubated with DNA (20 mg) 72 h, 48 h,
24 h or 0 h prior to the treatment with KLH (100 mg). After KLH
treatment (24 h), the peritoneal macrophages were fixed and CD4 T
cells specific for KLH were added to the culture. Proliferation was
measured after 72 h. Concanavalin A (40 mg/ml) was used as positive
control. * p,0.05 (OneWayANOVA).
doi:10.1371/journal.pone.0000923.g006
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interfere with MyD88 recruitment. We could still detect re-
cruitment of MyD88 to endosomes after plasmid treatment in spite
the alteration in the pH of the vesicles suggesting that the signaling
for recruitment of adaptor molecules was not changed. Although
we cannot exclude some downstream interference in this signaling
route, our results are in contrast with the work of Ahmad-Nejad et
al. [40] which showed that vesicle acidification is a prerequisite to
recruitment of MyD88. We believe that these different results
could be due to the stimulus used. We were looking at cell
activation using bacterial circular plasmid molecules, while
Ahmad-Nejad et al. [40] used a linear stimulatory bacterial
DNA (CpG motif).
Since our results demonstrated that plasmid DNA inhibits the
acidification of late endosomes/lysosomes, we analyzed if this
phenomenon could impair antigen presentation by class II MHC
molecules. Our results demonstrate that the presentation of KLH
antigen, by class II MHC, was impaired if the cells were incubated
with low doses (20 mg) of DNA before or at the same time as KLH
stimuli. Furthermore, the production of inflammatory cytokines
stimulated with DNA was dose dependent, lower DNA doses
producing less cytokines (data not showed). These results suggest
that the DNA molecule could be used to control the immune
response in inflammatory processes. It is known that proteolytic
enzymes are responsible for degradation of protein antigens and
this is dependent on the acidic pH of the endosome/lysosome
compartment. Moreover, proteolytic enzymes also act on the
invariant chain of the class II MHC molecules [47]. Since plasmid
DNA inhibited the acidification of the late endosome/lysosomes,
we hypothesize that this may also inhibit these proteolytic enzymes
resulting in an absence of antigen degradation and impairment of
KLH antigen presentation. Further studies are required to verify
this hypothesis. Although these data were unexpected, they could
change the way plasmid DNA is used in immune response
activation.
Recently Accapezzato et al. [48] showed that the use of
chloroquine, a lysosomotropic agent, improved the cross pre-
sentation in immature dendritic cells to CD8 T cells, by increasing
the export of antigen from lysosomes to the cytosol. We did not
analyze whether a cross presentation of antigen to CD8 T cells was
present in our system, but we can not exclude this possibility, since
the plasmid DNA interfered with the pH of the late endosomal/
lysosomal compartment in different antigen presenting cells.
The current results imply a new intracellular route for plasmid
DNA trafficking in vesicles to nuclei that may ensure that bacterial
plasmids avoid intracellular degradation. However, the exact
mechanism still remains to be elucidated. Taken together these
results suggest a wide range of applications for naked DNA
including studies on antigen presentation since these results suggest
that lower plasmid DNA concentrations can be used to control the
immune response (the use of lower doses of plasmid DNA to
regulate the immune response was deposited with the patent
number 0.700.698-5/I.N.P.I./SP).
MATERIALS AND METHODS
Cell culture
The macrophage line Raw-Myd88GFP, TLR9 KO cells (both
kindly provided by Dr. Hermann Wagner, Institute of Medical
Microbiology, Immunology and Hygiene, Munich, Germany), the
J774 macrophage line, peritoneal macrophages (collected from
Balb/c mice by peritoneal lavage with PBS), and spleen-derived
dendritic cells (SDCs) were used for studying the cellular uptake
and trafficking of plasmid DNA. Dendritic cells (SDCs) were
derived from the spleen of mice (Balb/c) and maintained, in low
adherence plates, as described by West et al. [49], in RPMI
medium supplemented with 10% fetal calf serum (Invitrogen,
Gibco, Carlsbad, CA), 100 mM sodium pyruvate, 10 mM non
essentials aminoacids, 10 mg/mL kanamicin, 200 mM glutamine,
10 mM b-mercaptoethanol, 10 ng/mL GM-CSF (R&D Systems,
Minneapolis, USA) and 1 ng/mL TGF-b (R&D Systems,
Minneapolis, USA) for 14 days (medium was replaced every
2 days) before use. The other cells (J774, Raw-Myd88GFP and
peritoneal macrophages) were cultured in RPMI 1640 medium,
supplemented with 10% FCS (Gibco), 100 UI/mL penicilin-
streptomicin (Gibco) and 10 mg/mL gentamicin (Gibco). All cells
were cultured at 37u in a humidified atmosphere of 5% CO2 in air.
Plasmid
The plasmid pcDNA3-Hsp65 contained the cytomegalovirus
(CMV) promoter and a cDNA encoding the gene for M. leprae
heat shock protein 65 kDa which has previously been described
(Lowrie et al., 1999). DH5 a E. coli transformed with pcDNA3-
Hsp65 was cultured in LB liquid medium (Gibco, Grand Island,
NY, USA) containing ampicilin (100 mg/mL, Cilinon
TM). The
Figure 7. Uptake of DNA was independent of TLR9 receptor and
recruitment of Myd88 was not affected. TLR9 KO cells were incubated
with DNA-Alexa 594 (red-A and B) for 1 hour. The DNA was internalized
by these cells. Raw cells (C–E) expressing GFP-tagged MyD88, were
incubated with DNA-Alexa 594 (red-D) for 1 hour. Colocalization of GFP-
Myd88 and fluorescent DNA was observed in vesicles (Arrows, yellow
fluorescence–E).
doi:10.1371/journal.pone.0000923.g007
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purification kit (QIAGEN AG, Basel, Switzerland). Plasmid
concentration was determined by spectrophotometry at l=260
and 280 nm using the Gene Quant II apparatus (Pharmacia
Biotech, Buckinghamshire, UK). The purity of DNA preparations
was confirmed by electrophoresis on a 1% agarose gel.
Plasmid DNA labeling
Plasmid DNA was labeled with Alexa Fluor 488 or 594 by
Universal Linkage System (ULS
TM) using the ULYSIS nucleic
acid labeling kit (Invitrogen, Molecular Probes, Inc., Carlsbad,
CA) with modifications as described by Coelho-Castelo et al [50].
Briefly, the plasmid DNA (8 mg) in labeling buffer (25 mL) was
denatured at 95uC for 5 minutes and cooled on ice. The ULS
labeling reagent stock solution (2.5 mL) was added to the tube and
the reaction incubated at 80uC for 15 minutes. The labeled DNA
was purified by ethanol precipitation, followed by resuspension in
PBS. The conformation of labeled plasmid prepared in this way
was not altered (data not shown). No free dye was associated with
the DNA.
Confocal laser microscopy
J774, Raw-Myd88GFP, peritoneal macrophages or SDCs were
plated 24 h prior to the experiment on glass 8 well chamber slides
(Lab-Tek Chamber Slide System, Nalge Nunc International,
Rochester, NY) at 2610
4 cells/wells in RPMI medium, without
phenol red, with 10% FCS. For the experiments involving Alexa
594 transferrin (14 mg/mL-Invitrogen, Molecular Probes, Inc.,
Carlsbad, CA), J774 cells were incubated with 4 mg of the Alexa
Fluor 488-labeled pcDNA3-Hsp65 in medium containing Alexa
594 transferrin for 30 minutes or the marker was added first and
after 15 minutes fluorescent DNA was added for an additional
15 minutes. For experiments involving LysoTracker Red
(160 nM- Invitrogen, Molecular Probes, Inc., Carlsbad, CA),
J774 cells, peritoneal macrophages or SDCs, were incubated with
Alexa Fluor 488-labeled pcDNA3-Hsp65 (4 mg) for varying times
(1 h–120 h) and LysoTracker Red was added for the last
30 minutes. For the DQ Ovalbumin experiments (Invitrogen,
Molecular Probes, Inc., Carlsbad, CA) SDCs were incubated
simultaneously with Alexa Fluor 594-labeled pcDNA3-Hsp65
(4 mg) and DQ Ovalbumin for varying times (1 min, 24 h and
72 h). For the Texas Red dextran experiments (10.000 MW,
10 mg/mL-Invitrogen, Molecular Probes, Inc., Carlsbad, CA),
peritoneal macrophages were treated with Alexa Fluor 488-labeled
pcDNA3-Hsp65 (4 mg) in growth medium containing Texas Red
dextran for 24 hours. After the cells were incubated with
fluorescent DNA plus Texas Red dextran, they were washed
twice with PBS, fixed for 15 minutes with 2% paraformaldehyde
in PBS, rinsed in PBS and coverslips mounted with Fluormount
(EM Sciences, Hatfield, PA). For the Rab 5 (BD Transduction
Laboratories, New Bedford, MA, USA) and Lamp I (Santa Cruz
Biotechnology, Inc., Santa Cruz, California) experiments, J774
cells were treated with Alexa Fluor 488-labeled pcDNA3-Hsp65
(4 mg) for various times (5 min and 15 min for Rab 5; and
24 hours for Lamp I) and after treatment cells were washed twice
with PBS, fixed for 15 minutes with 2% paraformaldehyde in PBS.
rinsed in PBS and nonspecific antibody binding sites were blocked
with 3% bovine serum albumin and donkey IgG in PBS for
1 hour. The cells were immunostained by incubating them with
primary antibody (Rab 5 or Lamp I) in blocking buffer (PBS
containing 1% bovine serum albumin) containing 0.01% saponin
at room temperature for 45 minutes, rinsed and then incubated in
blocking buffer with secondary antibody labeled with Alexa 594 at
room temperature for 45 minutes. The J774, Raw-Myd88GFP
and peritoneal macrophages were examined by confocal (Leica
TCS SP2 AOBS, Leitz, Manheim, Germany), or in the case of the
SDCs, by vital microscopy (LSM510META, Zeiss Germany). In
order to visualize Myd88 recruitment, Raw-Myd88GFP cells were
treated with Alexa Fluor 594-labeled pcDNA3-Hsp65 for 1 hour,
after they were washed twice with PBS, cover slips mounted with
Fluormount and examined by confocal microscopy (Leica TCS
SP2 AOBS).
Antigen presentation
BALB/c mice, 6 to 8 weeks old, were obtained from the Animal
Facilities of the School of Medicine of Ribeira ˜o Preto, University
of Sa ˜o Paulo, and were maintained under standard laboratory
conditions. 50 mg of Keyhole limpet haemocyanin (KLH, Sigma-
Aldrich, St. Louis, MO, USA) in 50 mL Freund’s complete
adjuvant (Sigma-Aldrich) was administered by subcutaneous
injection into each footpad. After 7 days another injection of
50 mg KLH in 50 mL Freund’s incomplete adjuvant was
administered into each footpad (total dose 200 mg of KLH).
CD4+ T cells from draining lymph nodes were purified by
magnetic beads (MicroBeads CD4-L3T4 Miltenyi Biotec GmbH,
Germany) 7 days after completion of immunization. Peritoneal
macrophages (collected from Balb/c mice by washing the
peritoneal cavity with PBS) were used as antigen presenting cells.
For the antigen presentation experiments, peritoneal macrophages
(5610
5 cells) were treated with DNA (20 mg) for 0 h, 24 h, 48 h,
or 72 h, prior to treatment with KLH (100 mg). After 24 hours
exposure to KLH, peritoneal macrophages were fixed and CD4 T
cells specific for KLH from immunized mice (5610
5 cells) was
added to the culture. CD4 T cells were cultured for an additional
72 hours and proliferation during the last 16 hours was quantified
by incubation with 0.5 mCi of 3H-thymidine (Amersham, Les Ulis,
France). Cells were collected onto filters and radioactivity was
measured in a scintillation counter (Beckman, Germany).
Concanavalin A (Con A–40 mg/ml; Sigma, St. Louis, MO,
USA) was used as positive control (T cell mitogen).
SUPPORTING INFORMATION
Figure S1 Treatment with chloroquine did not interfere with the
uptake and trafficking of DNA. Confocal images of J774 cells
incubated with DNA-Alexa 488 (green-A) or fluorescent DNA plus
cloroquine (B) for 4 h. (C) J774 cells incubated with LysoTracker
Red, a marker of late endosomes and lysosomes. (D): J774 cells
incubated with cloroquine plus LysoTracker Red. As the
cloroquine neutralizes the vesicles, the the Lysotracker Red does
not accumulate in lysosomes. (E): J774 cells in (D) incubated with
cloroquine plus LysoTracker Red visualized by differential
interference contrast.
Found at: doi:10.1371/journal.pone.0000923.s001 (5.63 MB TIF)
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